Valuation Report for Remedient Biomed Technologies

Part
01
of one
Part
01

Remedient Biomed Technologies Valuation

The valuation of the company Remedient Biomed Technologies and its product Gum Guard based on the Market Multiple valuation approach is $39.29 million.

Remedient Biomed Technologies Valuation

  • Biomed Technologies is a company that provides "high quality biomedical services to the healthcare community including on-site repair services, calibrations, preventive maintenance and safety inspections for different diagnostic, therapeutic, surgical, laboratory, and infection control equipment."
  • Syncona acquired SwanBio for $23 million for a 72% fully diluted stake, and Orbit Biomedical for $12 million for an 80% share. SwanBio is a biomedical company which provides services in the gene therapy field and focuses on the "development and commercialization of genetically defined therapies for the treatment of neurological disorders", while Orbit Biomedical is a biomedical company that is focused on the "delivery to the sub-retinal space for the treatment of retinal disease."
  • DLH Holdings Corp. acquired Social & Scientific Systems for $70 million. SSS is a biomedical services company that assists "mission-critical public health agencies within the Department of Health & Human Services — including the National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) — along with other healthcare-related institutions."

Research methodology

As Biomed Technologies is a biomedical services company that provides different services in the diagnostic, therapeutic, surgical, laboratory, and infection field, we looked into the acquisitions of three different companies that operate in the same field. We identified SwanBio, Orbit Biomedical, and Social & Scientific Systems as the companies which were acquired in the last 24 months and that operate in the same field.

Syncona acquired SwanBio for $23 million for a 72% fully diluted stake, and Orbit Biomedical for $12 million for an 80% share. In order to calculate the full value of each company, we triangulated as follows:
  • $23 million = 70%. To calculate the 100%: (23 million x 100) / 70 = 32.86 million
  • The full value of SwanBio is $32.86 million.
  • $12 million = 80%. To calculate the 100%: (12 million x 100) / 80 = 15 million
  • The full value of Orbit Biomedical is $15 million.
To calculate the average value of all three acquisition, we triangulated as follows:
  • ($32.86 million (SwanBio) + $15 million (Orbit Biomedical) + Social & Scientific Systems ($70 million)) / 3 = $39.29 million
  • The valuation of the company Remedient Biomed Technologies and its product Gum Guard based on the Market Multiple valuation approach is $39.29 million.
Sources
Sources